Your browser doesn't support javascript.
loading
Effect of butyrate-producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Nouso, Kazuhiro; Shiota, Shohei; Fujita, Rio; Wakuta, Akiko; Kariyama, Kazuya; Hiraoka, Atsushi; Atsukawa, Masanori; Tani, Joji; Tada, Toshifumi; Nakamura, Shinichiro; Tajiri, Kazuto; Kaibori, Masaki; Hirooka, Masashi; Itobayashi, Ei; Kakizaki, Satoru; Naganuma, Atsushi; Ishikawa, Toru; Hatanaka, Takeshi; Fukunishi, Shinya; Tsuji, Kunihiko; Kawata, Kazuhito; Takaguchi, Koichi; Tsutsui, Akemi; Ogawa, Chikara; Ochi, Hironori; Yata, Yutaka; Kuroda, Hidekatsu; Iijima, Hiroko; Matono, Tomomitsu; Shimada, Noritomo; Yasuda, Satoshi; Toyoda, Hidenori; Kumada, Takashi.
Affiliation
  • Nouso K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Shiota S; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Fujita R; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Wakuta A; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Kariyama K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Atsukawa M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Tani J; Department of Gastroenterology and Hepatology, Kagawa University, Takamatsu, Japan.
  • Tada T; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Nakamura S; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Tajiri K; Department of Gastroenterology, Toyama University Hospital, Toyama, Japan.
  • Kaibori M; Department of Surgery, Kansai Medical University, Hirakata, Japan.
  • Hirooka M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.
  • Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
  • Kakizaki S; Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
  • Naganuma A; Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
  • Ishikawa T; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Hatanaka T; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Fukunishi S; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tsuji K; Gastroenterology Center, Teine Keijinkai Hospital, Sapporo, Japan.
  • Kawata K; Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Takaguchi K; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Tsutsui A; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Ogawa C; Department of Gastroenterology, Japanese Red Cross Takamatsu Hospital, Takamatsu, Japan.
  • Ochi H; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Yata Y; Department of Gastroenterology, Hanwa Memorial Hospital, Osaka, Japan.
  • Kuroda H; Department of Gastroenterology, Iwate Medical University, Iwate, Japan.
  • Iijima H; Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University, Himeji, Japan.
  • Matono T; Department of Gastroenterology and Hepatology, St. Mary's Hospital, Himeji, Japan.
  • Shimada N; Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan.
  • Yasuda S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan.
  • Toyoda H; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan.
  • Kumada T; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
Cancer Med ; 12(17): 17849-17855, 2023 09.
Article in En | MEDLINE | ID: mdl-37563961

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Drug-Related Side Effects and Adverse Reactions / Liver Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Drug-Related Side Effects and Adverse Reactions / Liver Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication: